See the latest Alpine Immune Sciences Inc stock price (ALPN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) traded down 5.6% on Wednesday . The company traded as low as $36.80 and last traded at $37.02. 583,722 shares were traded during trading, a decline of 48% from the average session volume of 1,126,938 shares. The stock had previously closed at $39.21. Analyst […]
Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) have earned a consensus recommendation of “Buy” from the seven analysts that are currently covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average 12-month target price among brokerages that have covered the stock in the […]
Wolfe Research started coverage on shares of Alpine Immune Sciences (NASDAQ:ALPN – Free Report) in a report released on Thursday, MarketBeat.com reports. The brokerage issued an outperform rating and a $44.00 target price on the biotechnology company’s stock. Other analysts have also recently issued reports about the stock. Royal Bank of Canada lifted their target […]